Improving health outcomes for pregnant women in Kenya through STI testing
Official title: Improving Perinatal Outcomes Among Kenyan Pregnant Women With an Integrated STI Testing Model
Run by University of Washington · NCT06203951 · Data updated 2026-11-12
This study is testing different ways of checking for STIs during pregnancy to see which method helps improve the health of mothers and their babies in Kenya.
Quick facts
| Study type | Interventional |
|---|---|
| Sex | Women only |
| Enrollment | 3132 (estimated) |
| Sponsor | University of Washington Academic / other |
| Locations | 8 sites (Homa Bay and 7 other locations) |
| Status | Recruiting |
| Started | January 27, 2025 |
| Main results expected | December 31, 2027 |
| Study ends | December 31, 2028 |
| Registry record updated | July 16, 2025 |
| Trial ID | NCT06203951 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are cisgender women who are seeking antenatal services and are willing to participate in STI screening and testing.
✕Probably not a fit
Patients who are not seeking antenatal care or who do not identify as cisgender women may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This clinical trial aims to evaluate the effectiveness of three different models of STI testing and management during antenatal care for pregnant women in Kisumu and Siaya, Kenya. A total of 3,132 participants will be randomly assigned to receive either standard-of-care management or enhanced STI testing using Xpert® assays, with follow-up through nine months postpartum. The study will assess various perinatal outcomes, including pregnancy loss, preterm birth, low birth weight, and neonatal death, to determine which testing model yields the best results for maternal and infant health.
Why it matters
Potential benefit: If successful, this study could lead to improved perinatal outcomes for pregnant women by identifying and treating STIs more effectively.
How similar studies have gone: Previous studies have shown promising results with enhanced STI testing approaches in similar populations, suggesting potential for success in this trial.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Self-identifying as a cisgender woman * Seeking antenatal services from the clinic * Planning to receive antenatal and postnatal care at the clinic * Willingness to receive syndromic STI screening and HIV/syphilis testing per national guidelines * Able and willing to provide informed consent for participation Exclusion Criteria: * Male gender * Not seeking antenatal services from the clinic * Not planning to receive antenatal and postnatal care at the clinic * Not willing to receive syndromic STI screening and HIV/syphilis testing per national guidelines * Not able or willing to provide informed consent for participation
Where it's running
-
Homa Bay Teaching and Referral Hospital
Homa Bay, Kenya Recruiting -
Rachuonyo South Sub County Hospital
Homa Bay, Kenya Recruiting -
Rangwe Sub County Hospital
Homa Bay, Kenya Recruiting -
Chulaimbo County hospital
Kisumu, Kenya Recruiting -
Kisumu County Hospital
Kisumu, Kenya Recruiting -
Lumumba Sub County hospital
Kisumu, Kenya Recruiting
Show 2 more locations
-
Migosi Sub County Hospital
Kisumu, Kenya Recruiting -
Yala sub County Hospital
Yala, Kenya Recruiting
Study contacts
- Principal investigator: Jillian Pintye, RN, MPH, PHD — University of Washington
- Study coordinator: Lauren Gomez
- Email: gomezL4@uw.edu
- Phone: 206-685-5044
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Project SHIELD 2.0: Police Education to Support Public Health in Kentucky
Aimed at police in Kentucky, this program tests whether SHIELD training given to officers, with health workers helping deliver it, can reduce drug-related arrests and steer people who use drugs toward MOUD and other health services.
-
New ways to diagnose lymphoma and multicentric Castleman disease in people living with HIV
This study tests a quick, point-of-care nucleic acid test to help diagnose lymphoma and multicentric Castleman disease in people living with HIV in sub-Saharan Africa.
-
Bridge to Belonging: A Peer‑Led Program to Reduce Loneliness and Depression in older gay and bisexual men with HIV
This program tests a peer-delivered, manualized approach to help men aged 50+ with HIV connect to LGBTQ+-affirming elder services to see if it reduces loneliness and depressive symptoms.
-
HIV vaccine test in healthy adults using CH505 nanoparticles and mRNA boosters
This early-stage study will test the safety and immune responses of CH505 vaccine regimens in healthy adults to see if they can trigger HIV-specific immune protection.
-
Stigma-reducing program to help women who use drugs stay in HIV care
This test checks whether a stigma-reduction program helps women living with HIV who use drugs stay engaged in HIV care in Ukraine.
-
Platelets and HIV Reservoirs: A look at how platelets might harbor HIV in people living with HIV
This observational study tests whether HIV can be found inside platelets in adults with suppressed HIV on therapy.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.